These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34146935)

  • 41. Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38.
    Alibolandi M; Amel Farzad S; Mohammadi M; Abnous K; Taghdisi SM; Kalalinia F; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1003-1014. PubMed ID: 29806500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyaluronic acid-oleylamine and chitosan-oleic acid conjugate-based hybrid nanoparticle delivery via. dissolving microneedles for enhanced treatment efficacy in localized breast cancer.
    Jha A; Kumar M; Goswami P; Manjit M; Bharti K; Koch B; Mishra B
    Biomater Adv; 2024 Jun; 160():213865. PubMed ID: 38643693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles.
    Wang J; Tao X; Zhang Y; Wei D; Ren Y
    Biomaterials; 2010 May; 31(15):4426-33. PubMed ID: 20188412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in Chitosan-based Drug Delivery Systems in Melanoma: A Narrative Review.
    Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Yousefi B
    Curr Med Chem; 2024; 31(23):3488-3501. PubMed ID: 37202890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Smart co-delivery of plasmid DNA and doxorubicin using MCM-chitosan-PEG polymerization functionalized with MUC-1 aptamer against breast cancer.
    Esmaeili Y; Dabiri A; Mashayekhi F; Rahimmanesh I; Bidram E; Karbasi S; Rafienia M; Javanmard SH; Ertas YN; Zarrabi A; Shariati L
    Biomed Pharmacother; 2024 Apr; 173():116465. PubMed ID: 38507955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review.
    Ali DS; Othman HO; Anwer ET
    Curr Pharm Biotechnol; 2023; 24(12):1554-1559. PubMed ID: 36733239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy.
    Murugan C; Rayappan K; Thangam R; Bhanumathi R; Shanthi K; Vivek R; Thirumurugan R; Bhattacharyya A; Sivasubramanian S; Gunasekaran P; Kannan S
    Sci Rep; 2016 Oct; 6():34053. PubMed ID: 27725731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy.
    Tian B; Hua S; Liu J
    Carbohydr Polym; 2023 Sep; 315():120972. PubMed ID: 37230614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review.
    Suarato G; Li W; Meng Y
    Biointerphases; 2016 Dec; 11(4):04B201. PubMed ID: 27016506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
    Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
    Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chitosan nanopolymers: An overview of drug delivery against cancer.
    Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
    Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy.
    Lohiya G; Katti DS
    Carbohydr Polym; 2022 Feb; 277():118822. PubMed ID: 34893239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.
    Duceppe N; Tabrizian M
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1191-207. PubMed ID: 20836623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
    Naruphontjirakul P; Viravaidya-Pasuwat K
    Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
    [No Abstract]   [Full Text] [Related]  

  • 56. Chitosan-based nanotherapeutics for ovarian cancer treatment.
    Alizadeh L; Zarebkohan A; Salehi R; Ajjoolabady A; Rahmati-Yamchi M
    J Drug Target; 2019 Sep; 27(8):839-852. PubMed ID: 30596291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers.
    Dou T; Wang J; Han C; Shao X; Zhang J; Lu W
    Int J Biol Macromol; 2019 Oct; 138():791-799. PubMed ID: 31356947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
    Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
    Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydroxyurea-loaded Fe
    Chaghervand MM; Torbati MB; Shaabanzadeh M; Ahmadi A; Tafvizi F
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):51-63. PubMed ID: 34661718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.